Active ingredientAnagliptinCat. No. P-A151-001CAS 739366-20-2Family · Pharmaceutical analytical standards
Anagliptin
A DPP-4 inhibitor (gliptin) for type 2 diabetes, approved in Japan in 2012: it helps control blood glucose by prolonging the action of incretins, the gut hormones released after meals. This family brings together the active ingredient, labelled standards, nitrosamines and other impurities.
Did you know?Its crystal structure bound to the DPP-4 enzyme shows that it does not mimic the enzyme's natural substrates: it attaches only through non-covalent interactions, for instance between its cyano group and a serine in the active site.
Go to the active ingredient →Active ingredientAnagliptinCat. No. P-A151-001CAS 739366-20-2
Isotopically labelledAnagliptin-d6Cat. No. P-A151-002
NitrosamineN-Nitroso AnagliptinCat. No. P-A151-003
ImpurityAnagliptin Impurity 1Cat. No. P-A151-004No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.